Results 171 to 180 of about 37,984 (216)
The Fatty Pancreas: Current Evidence, Treatment Implications, and Future Directions. [PDF]
Syed KA +6 more
europepmc +1 more source
This meta‐analysis demonstrates high diagnostic accuracy of computer‐assisted methods in pancreatic EUS‐FNA cytology (AUC 0.92–0.96) and supports an integrated, cytopathologist‐led workflow in which artificial intelligence functions as an adjunct to diagnostic interpretation and on‐site evaluation (ROSE). Created in BioRender. Mohamed Mirzan, A. (2026)
Al‐Amaan Mohamed Mirzan, Roberto Dina
wiley +1 more source
A sensor-fault resilient artificial pancreas using type-3 fuzzy logic and predictive controls. [PDF]
Mai VT +3 more
europepmc +1 more source
Pediatric paroxysmal non‐epileptic events (PNEs) are frequently misdiagnosed as epilepsy. We systematically reviewed and synthesized 40 studies, including 3123 video‐EEG monitored pediatric patients. Epileptic seizures in infants (1 month–3 years) typically presented as arrest, while in children and adolescents (1 month–21 years) they manifested as ...
Tímea Lőrincz‐Molnár +8 more
wiley +1 more source
Trustworthy artificial intelligence in predictive medicine: cancer survival analysis using ethical-by-design and explainable artificial intelligence models. [PDF]
Farahani S +12 more
europepmc +1 more source
Abstract Background Pump and sensor technology contributes to glucose management and quality of life for people with type 1 diabetes (PWD). However, not everyone uses these technologies. This commonly relates to technological attitudes, experiences and expectations. Also, parents and partners (P/P) and healthcare providers (HCPs) may impactful decision‐
M. Horsselenberg +4 more
wiley +1 more source
Editorial: Organ transplantation by 2040. [PDF]
Kupiec-Weglinski JW, Busuttil RW.
europepmc +1 more source
Abstract Aims CGM devices report glucose only within fixed limits (typically 40–400 mg/dL; 2.2–22.2 mmol/L), truncating extreme values to a boundary (‘capping’). We characterised prevalence, duration, and consequences of capping in type 1 diabetes trial data.
John F. Mulley
wiley +1 more source
Machine learning and artificial intelligence in liquid biopsy-based early detection of pancreatic cancer: a scoping review. [PDF]
Ku J, Singhal M, Burnette M, Hegazy SA.
europepmc +1 more source
AI and Epigenetics: A New Opportunity for Early Pancreatic Cancer Detection in Australia
ANZ Journal of Surgery, EarlyView.
Jaswinder S. Samra +2 more
wiley +1 more source

